What is the reinitiation schedule for Sustenna (paliperidone) 150mg depot after a missed dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Reinitiation Schedule for Missed Paliperidone Palmitate (Sustenna) 150mg Depot Injection

For a missed Sustenna 150mg depot injection from September 5, you should restart with the full initiation schedule of 150mg eq. on day 1 followed by 100mg eq. on day 8, both administered in the deltoid muscle.

Understanding Paliperidone Palmitate (Sustenna)

  • Paliperidone palmitate is a long-acting injectable (LAI) antipsychotic with a half-life of 24-49 days, depending on dose 1
  • After injection, the drug release starts as early as day 1, reaches maximum plasma concentration at 13 days, and can last up to 126 days 2
  • The medication comes in prefilled syringes with multiple dosage strengths and does not require refrigeration 2

Reinitiation Protocol Based on Time Since Last Dose

When more than 6 weeks have passed since the last maintenance dose (which is your case), a complete reinitiation schedule is required:

  • Day 1: Administer 150mg equivalent (234mg paliperidone palmitate) in the deltoid muscle 3
  • Day 8: Administer 100mg equivalent (156mg paliperidone palmitate) in the deltoid muscle 3
  • Use appropriate needle size based on patient weight:
    • <90kg: 1-inch 23-gauge needle 3
    • ≥90kg: 1.5-inch 22-gauge needle 3
  • After reinitiation, resume monthly maintenance dosing (typically 75mg eq. is recommended, but continue with 150mg if that was your established maintenance dose) 3

Important Administration Considerations

  • The deltoid muscle is required for the loading doses to achieve therapeutic concentrations rapidly (approximately 28% higher concentration compared to gluteal injection) 2
  • No oral supplementation is required during reinitiation 2, 3
  • The day 8 dose may be administered ±2 days without clinically significant impact on plasma concentrations 3

Monitoring After Reinitiation

  • Monitor for common side effects including:
    • Injection site reactions (4-10% depending on dose regimen) 2
    • Extrapyramidal symptoms (more common at higher doses) 2
    • Weight changes 2

Prevention of Future Missed Doses

  • Set reminders for future doses to improve adherence 4
  • Document any missed doses to report to your healthcare provider at your next appointment 5
  • Keep extra documentation of injection appointments in multiple locations 5

Clinical Importance of Adherence

  • Missing doses of long-acting antipsychotics can lead to symptom recurrence and potential relapse 2
  • Proper reinitiation is critical to maintain therapeutic drug levels and clinical efficacy 3
  • Following the recommended reinitiation protocol helps ensure optimal clinical outcomes and reduces the risk of hospitalization 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.